This manuscript proposes a novel approach to determine optimal screening intervals for breast cancer patients, aiming to balance screening costs and delays. The methodology employs a personalized strategy, incorporating individual patient medical histories alongside external data. Overall, the paper is well-structured and clearly written, with the proposed technique demonstrating substantial enhancements over current approaches.